Want to join the conversation?
$FISV 2Q15 Q&A: David from Evercore asked, should we expect financial segment revenue growth to exit the year closer to mid-single digit, & Tom replied we're going to continue to see acceleration in both segments in second half of year. Segment is impacted by license revenue in different sorts of things, we are going to have an acceleration in 2016
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?